Bristol-Myers Squibb Company (BMY)
Operating return on assets (Operating ROA)
| Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 12,696,000 | 9,658,000 | 8,472,000 | 9,271,000 | 9,540,000 |
| Total assets | US$ in thousands | 90,038,000 | 92,603,000 | 95,159,000 | 96,820,000 | 109,314,000 |
| Operating ROA | 14.10% | 10.43% | 8.90% | 9.58% | 8.73% |
December 31, 2025 calculation
Operating ROA = Operating income ÷ Total assets
= $12,696,000K ÷ $90,038,000K
= 14.10%
Peer comparison
Dec 31, 2025
Company name
Symbol
Operating ROA
Bristol-Myers Squibb Company
BMY
14.10%
AbbVie Inc
ABBV
—
Amgen Inc
AMGN
16.44%
Biogen Inc
BIIB
6.38%
Eli Lilly and Company
LLY
26.40%
Gilead Sciences Inc
GILD
—
Johnson & Johnson
JNJ
12.85%
Merck & Company Inc
MRK
—
Pfizer Inc
PFE
—